Elisabeth Ban

722 citations
16 papers · 557 indexed · h-index 12
Topics
Immune Response and Inflammation (9 papers)Immunotherapy and Immune Responses (5 papers)Growth Hormone and Insulin-like Growth Factors (3 papers)

In The Last Decade

Elisabeth Ban

16 papers receiving 548 citations

Peers

Elisabeth Ban
Comparison fields: 5 of 73
  • Immunology 311
  • Epidemiology 142
  • Molecular Biology 135
  • Endocrinology, Diabetes and Metabolism 58
  • Behavioral Neuroscience 49
Replace A. Moerman with:
A. Moerman United States
Flemming Kristensen Switzerland
Yoshiko Nagaoka United States
Andrea S. Bertke United States
Ippei Sakakibara Japan
E. Dahme Germany
Herbert L. Ratcliffe United States
Julia W. Albright United States
Nigel Horscroft United States
Jinliang Wang China
Elisabeth Ban relative to A. Moerman United States A. Moerman's profile →
Citations per field
00.5×3.8×
A. Moerman · 1×
Citations per year

Countries citing papers authored by Elisabeth Ban

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Ban more than expected).

Fields of papers citing papers by Elisabeth Ban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Ban. The network helps show where Elisabeth Ban may publish in the future.

Co-authorship network of co-authors of Elisabeth Ban

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Ban. A scholar is included among the top collaborators of Elisabeth Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Ban. Elisabeth Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 20
2 23
3 9
4 35
5 57
6 127
7 30
8 31
9 37
10 33
11 31
12 9
13 45
14 5
15 10
16 55

About Elisabeth Ban

Elisabeth Ban is a scholar working on Immunology, Microbiology and Reproductive Medicine, having authored 16 papers that have together received 557 indexed citations. Recurring topics across this work include Immune Response and Inflammation (9 papers), Immunotherapy and Immune Responses (5 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). The work is most often cited by research in Immunology (311 citations), Behavioral Neuroscience (49 citations) and Biological Psychiatry (16 citations). Elisabeth Ban has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include F. Haour, Jerry R. McGhee, Miroslav Novák, Jiří Městecký, Zina Moldoveanu, Loı̈c Dupré, Huan Huu Nguyen, Frederik W. van Ginkel, Hiroshi Kiyono and Gilles Riveau. Their work appears in journals such as Journal of Biological Chemistry, Endocrinology and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026